Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Retains Top Slot In Generics/Biosimilar Rankings As Industry Faces US Pushback

Executive Summary

With Mylan snapping at its heels, Israel’s Teva managed to retain top slot in the latest Generics Bulletin rankings. Severe pricing and margin pressures in the US market made like difficult for generics companies in 2017, with eight of the top 20 firms reporting year on year sales declines.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123330

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel